Materiały źródłowe

• #1 Cerebral Cavernous Malformations – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK538144/

  Cerebral cavernous malformations (CCMs), also known as cavernomas or cavernous hemangiomas, are clusters of abnormal capillaries lacking intervening brain tissue. […] Diagnosis is typically made through characteristic lesions on imaging. […] The natural history and treatment strategies for CCMs continue to evolve, emphasizing the importance of individualized care. […] Determine appropriate diagnostic studies when evaluating patients with cerebral cavernous malformations. […] Imaging is generally recommended that new symptoms warrant repeat imaging to assess for acute or subacute hemorrhage. […] A detailed understanding of imaging and diagnostic criteria, supported by advanced techniques, enhances the clinician’s capability to manage CCMs effectively while minimizing unnecessary interventions.

• #1 Cerebral Cavernous Malformations – StatPearls – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK538144/

  When parenchymal hemorrhage is diagnosed, follow-up imaging with contrast-enhanced MRI is indicated to assess for an underlying vascular lesion. […] MRI is nearly 100% sensitive for CCM detection, making it the diagnostic modality of choice. […] Genetic testing is advised for patients with multiple CCMs or a family history of the condition. […] The following recommendations should be kept in mind in the management of CCMs: According to the 2017 Angioma Alliance Care Guidelines, surgical resection is not recommended for asymptomatic lesions, particularly those in eloquent or deep brain regions. […] The risks and benefits of surgical or radiotherapeutic intervention must be assessed on a case-by-case basis, and the prospective risks of untreated CCM must be balanced with the anticipated intervention morbidity.

• #1 Cerebral cavernous venous malformation | Radiology Reference Article | Radiopaedia.org

  https://radiopaedia.org/articles/cerebral-cavernous-venous-malformation?lang=us

  Cerebral cavernous venous malformations, also commonly known as cavernous hemangiomas or cavernomas, are common cerebral vascular malformations, usually with characteristic appearances on MRI. It is the third most common cerebral vascular malformation after developmental venous anomaly and capillary telangiectasia. […] Brain MRI with SWI or GRE is recommended for the investigation and follow-up of cerebral cavernous malformations. For investigation of new symptoms suspicious for cerebral hemorrhage, CT can be used within 1 week of onset and MRI after 1 week. […] Many cavernous malformations are asymptomatic and can be treated conservatively. Symptoms can relate to mass effect, epileptic activity or repeated hemorrhage. Symptomatic lesions should, when possible, be resected and complete resection is curative. […] Cavernous malformations are angiographically occult and do not demonstrate arteriovenous shunting. DSA is useful to differentiate a cerebral cavernous malformation from an arteriovenous malformation or developmental venous anomaly.

• #1 Imaging – Alliance to Cure Cavernous Malformation

  https://www.alliancetocure.org/cavernous-angioma-in-depth/diagnosis-imaging/

  While some people with cavernous malformations (also known as cavernoma, cavernous angioma) receive their diagnosis through genetic testing or surgery, the vast majority are diagnosed via imaging, typically magnetic resonance imaging (MRI). Imaging technology has advanced over the years and research into new techniques is ongoing. […] An MRI is the standard of care for cavernous malformation, especially when performed on an MRI machine with a magnet strength of 3 Tesla (3T) or 7 Tesla (7T, currently used in research settings) and when the imaging includes susceptibility-weighted sequences (SWI). Specific recommendations for physicians who order or perform MRI are included in the Alliance to Cure Cavernous Malformation Clinical Care Consensus Guidelines. […] A distinctive feature of a cavernous malformation when it is visualized on MRI is the hemosiderin ring around the lesion. Hemosiderin is iron, a byproduct of the breakdown of blood.

• #1 Cavernous malformations – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/cavernous-malformations/diagnosis-treatment/drc-20360942

  If your treatment plan includes surgery, more-advanced imaging technologies may be useful. […] You may have a functional MRI, which measures blood flow in the active parts of the brain. […] Another option is tractography, which creates a map of the brain to make surgery as safe as possible. […] The outlook of cerebral cavernous malformations depends on many factors, including their size, growth and whether they cause symptoms. […] Some CCMs don’t cause any symptoms at all, while others can cause serious bleeding in the brain. […] Experts are looking at using imaging technology to improve predictions of the course of disease in some people. […] They’re also looking at using imaging to get more information about a particular individual’s disease state. […] These technologies include imaging through quantitative susceptibility mapping and permeability imaging using dynamic contrast-enhanced MRI.

• #1 Imaging – Alliance to Cure Cavernous Malformation

  https://www.alliancetocure.org/cavernous-angioma-in-depth/diagnosis-imaging/

  Research is ongoing to validate and standardized two advanced techniques in MRI imaging: quantitative susceptibility mapping (QSM) and dynamic contrast-enhanced quantitative permeability imaging (DCEQP). Both of these techniques are being used in clinical drug trials to measure whether medicine is making a difference in the activity of a cavernous malformation. […] Functional MRI (fMRI) provides information on the precise location of certain functions, for example, speech, in the brain. It may be used before surgery to allow the surgeon to plan a route to the cavernous malformation lesion that avoids a specific area.

• #1 Cavernous Angioma (Malformation) Imaging and Diagnosis: Practice Essentials, Computed Tomography, Magnetic Resonance Imaging

  https://emedicine.medscape.com/article/337534-overview

  CT scanning has only a limited role in the diagnosis of cavernous angiomas, largely because of its relative lack of specificity. CT scan findings are compatible with low-grade gliomas, hematomas, granulomas, and inflammatory conditions such as tuberculomas and sarcoidomas. When calcified and located near the dura, cavernous angiomas can even resemble meningiomas. CT images also cause small lesions to be missed altogether, and cavernomas, when they present as acute intracerebral hematomas, may not be detected by nonenhanced CT scanning. […] […] MRI has largely replaced conventional angiography in the diagnosis of cavernomas. However, when the lesions occur in combination with other types of vascular malformations, as they do in as many as 30% of patients with venous angiomas, MRI characteristics become more complicated and less specific. In these patients, angiography can help further define the lesions.

• #1 Cavernous Malformations – AANS

  http://www.aans.org/patients/conditions-treatments/cavernous-malformations/

  Cavernous malformations are part of a group of lesions known as angiographically occult vascular malformations. This means that they are not visible on an angiogram. Angiograms cannot visualize cavernous malformations, because blood flows through these types of lesions slowly. The relatively milder symptoms from the lesion, even when ruptured, are presumed to be related to this state of relatively low blood flow. […] Magnetic resonance imaging (MRI), with and without contrast and with gradient echo sequences, remains the best means of diagnosing cavernous malformations. MRI scans may need to be repeated to analyze a change in the size of a cavernous malformation, recent bleeding or the appearance of new lesions.

• #1 Familial multiple cavernous malformation syndrome | Radiology Reference Article | Radiopaedia.org

  https://radiopaedia.org/articles/familial-multiple-cavernous-malformation-syndrome?lang=us

  The definition of familial multiple cavernous malformation syndrome is when there is one or more of the following: […] mutations in one of the three genes, KRIT1, CCM2 or PDCD10, which are associated with this disease. […] Familial cases usually have an autosomal dominant pattern of inheritance with incomplete penetrance.

• #1 Invitae Cerebral Cavernous Malformations Panel | Test catalog | Invitae

  https://www.invitae.com/us/providers/test-catalog/test-04422

  Depending on ethnicity, 10%50% of individuals with CCM present as familial cases with dominant inheritance and variable penetrance. Some sporadic cases may actually be familial but without symptoms seen in individuals who have pathogenic genetic changes. Familial cases tend to have more brain lesions (observable by neuroimaging) and suffer from hemorrhages more than twice as often as sporadic cases and throughout their adult lives. […] Pathogenic variants in three genes explain the etiology in approximately 80% of familial CCM cases, with KRIT1 showing the highest clinical yield (approximately 55%), followed by CCM2 (approximately 15%) and PDCD10 (approximately 10%). […] Invitae is a College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified clinical diagnostic laboratory performing full-gene sequencing and deletion/duplication analysis using next-generation sequencing technology (NGS). […] Based on validation study results, this assay achieves 99% analytical sensitivity and specificity for single nucleotide variants, insertions and deletions 15bp in length, and exon-level deletions and duplications.

• #1 Cavernous malformations – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/cavernous-malformations/diagnosis-treatment/drc-20360942

  A Mayo Clinic neurologist talks with a person about a diagnosis. […] Depending on why the condition is suspected, your healthcare professional may order tests to confirm CCMs or to identify or rule out other related conditions. […] You may have imaging tests to look for changes in the blood vessels. […] An MRI is administered to a person. […] If you have a family history of the condition, genetic counseling and blood or saliva tests can help find gene changes related with CCMs. […] The tests can show if there’s bleeding or new CCMs. […] Your healthcare team reviews your symptoms and imaging tests to decide on a treatment plan. […] The care team may recommend closely watching the cavernous malformation is recommended. […] Or your care team may recommend removing or treating the cavernous malformation.

• #1 Invitae Cerebral Cavernous Malformations Panel | Test catalog | Invitae

  https://www.invitae.com/us/providers/test-catalog/test-04422

  Test code: 04422 […] The Invitae Cerebral Cavernous Malformations Panel analyzes three genes that are associated with hereditary vascular cavernous malformations in the brain. These genes were selected based on the available evidence to date to provide appropriate testing for cerebral cavernous malformations (CCM). […] Genetic testing of these genes may confirm a diagnosis and help inform treatment and management decisions. Identification of a disease-causing variant would also guide testing and diagnosis of at-risk relatives. […] Cerebral cavernous malformations (CCMs) are abnormal collections of blood capillaries in the brain and spinal cord. These vascular malformations are characterized by reduced elasticity and thin blood vessels that are susceptible to hemorrhage. CCMs are a small subset of cerebral vascular malformations and can be recognized through neuroimaging. More than half of all individuals with CCMs become symptomatic, most frequently exhibiting seizures, headaches, focal neurological deficits, and cerebral hemorrhages.

• #1 Familial Cerebral Cavernous Malformations – GeneReviews® – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK1293/

  Familial cerebral cavernous malformations (FCCM) is a disorder characterized by multiple vascular lesions in the brain and spinal cord that consist of clustered, endothelial-lined caverns ranging in diameter from a few millimeters to several centimeters. […] The diagnosis of familial cerebral cavernous malformations (FCCM) is established in a proband with multiple CCMs, one CCM and at least one other family member with one or more CCMs, or a heterozygous germline pathogenic variant in KRIT1, CCM2, or PDCD10 identified by molecular genetic testing. […] FCCM should be suspected in individuals with the following clinical findings, brain and/or spinal cord imaging findings, and family history. […] The clinical diagnosis of FCCM can be established in a proband with multiple CCMs or one CCM and at least one other family member with one or more CCMs.

• #1 Familial Cerebral Cavernous Malformations – GeneReviews® – NCBI Bookshelf

  https://www.ncbi.nlm.nih.gov/books/NBK1293/

  The molecular diagnosis can be established in a proband with suggestive findings and a heterozygous germline pathogenic (or likely pathogenic) variant in KRIT1, CCM2, or PDCD10 identified by molecular genetic testing. […] No consensus clinical diagnostic criteria for familial cerebral cavernous malformations (FCCM) have been published.

• #1 SciELO Brazil – Neurocysticercosis, familial cerebral cavernomas and intracranial calcifications: differential diagnosis for adequate management Neurocysticercosis, familial cerebral cavernomas and intracranial calcifications: differential diagnosis for

  https://www.scielo.br/j/anp/a/pKsTMJ4757wpkzmcYwssGQR/

  Neurocysticercosis (NCC) is an endemic disease and important public health problem in some areas of the World and epilepsy is the most common neurological manifestation. […] Cerebral cavernous malformations (CCM), also known as cerebral cavernomas, are frequent vascular malformations of the brain, better demonstrated by MRI and have also epilepsy as the main form of clinical presentation. […] In the countries, and geographic areas, where NCC is established as an endemic health problem and neuroimaging screening is done by CT scan, it will be important to consider the differential diagnosis between the two diseases due to the differences in adequate management. […] The familial form of cerebral cavernomas (FCCM) is characterized by multiple brain lesions, usually as the result of loss-of-function mutations in one of the known CCM genes.

• #1

  https://link.springer.com/article/10.1007/s00701-018-3735-1

  There are histopathological findings supporting the term pseudocavernoma as significant histopathological differences exist between pseudocavernomas and CM. […] Imaging characteristics of pseudocavernomas sometimes deviate from that of CMs. […] Another observation supporting the existence of pseudocavernomas is that a radiation-induced CM disappeared following administration of bevazizumab, just as radiation-induced complications sometimes do. […] Clinically, Cutsford-Gregory et al. found that asymptomatic pseudocavernomas had a higher incidence of hemorrhages as compared to asymptomatic CMs. […] Based on the arguments above, it can be concluded that pseudocavernomas exist and should be considered to be a differential diagnosis to radiation-induced CMs in the future. […] In conclusion, our own cases as well as our literature review support that at least some of the radiation induced CMs, especially those which develop following radiosurgery, have little in common with CMs and thus the term pseudocavernoma is appropriate in these cases.

• #1 Cavernous Malformation – 20 Questions Answered

  https://www.alliancetocure.org/home/for-patients/newly-diagnosed/20-questions-answered-cavernous-malformation-angioma-cavernoma/

  The rarest place for a symptomatic cavernous malformation is in the spinal cord. A spinal cord cavernous malformation is not the same as a spinal hemangioma, which is located in the vertebra (bone). Cavernous malformations may also occur in the area of the brain called the brainstem. Spinal cord and brainstem cavernous malformations can cause more severe symptoms when they hemorrhage. […] Your doctor may have discovered your cavernous malformation (cavernous angioma, cavernoma) when you had brain or spinal imaging for a reason not related to your cavernous malformation. For example, you may have received a CT scan or an MRI after a car accident or concussion. In this case, doctors will call your cavernous malformation an incidental finding. Research has shown that incidental cavernous malformations that have not had a previous hemorrhage have a very small chance of ever becoming problematic.

• #1 Spinal Cavernous Malformations Diagnosis & Treatment – NYC | Columbia Neurosurgery in New York City

  https://www.neurosurgery.columbia.edu/patient-care/conditions/spinal-cavernous-malformations

  A cavernous malformation is an abnormal collection of tiny blood vessels called capillaries. Cavernous malformations can occur anywhere in the body, and in many locations they are harmless. In the spinal cord, however, they can present a problem. At the Spine Hospital at the Neurological Institute of New York, we specialize in cavernous malformations of the spinal cord. […] Magnetic resonance (MR) scans are the most useful diagnostic study for cavernous malformations. These scans use large magnets, radiofrequencies, and a computer to produce detailed images of organs and structures inside the body. […] Computed tomography scans (CT scans, or CAT scans) may also be used. These scans use X-rays and a computer to produce detailed images of bones, muscles, fat, and organs. […] Molecular genetic testing is available to confirm the diagnosis of familial cavernous malformation. It is not a useful test in most cases of sporadic cavernous malformationin those cases, the genetic form is already ruled out by the isolated lesion and lack of family history of the disease.

• #1 Cavernoma Program | Pacific Stroke & Neurovascular Center

  https://www.pacificneuroscienceinstitute.org/stroke-neurovascular/conditions-and-treatments/brain-vascular-malformation/cavernoma/cavernoma-program/

  The Cavernoma Program specializes in advanced diagnostics to optimize treatment decisions, including state-of-the-art brain imaging and genetic profiling of vascular malformations to identify targets for therapeutic intervention. […] We use state-of-the-art brain imaging techniques (called diffusion tensor tractography, gradient echo and susceptibility weighted sequences) that allow for noninvasive and computational treatment planning. […] Most cavernomas only need to be observed with routine brain imaging, repeated over time to observe for changes in appearance, recent bleeding (hemorrhage) or appearance of new lesions. […] The Cavernoma Program is also a leader in advanced research initiatives to develop targeted molecular therapies with the goal of preventing new cavernoma formation and protecting against symptomatic bleeding.

• #1 Orphanet: Familial cerebral cavernous malformation

  https://www.orpha.net/en/disease/detail/221061

  Regular check-ups, generally with an MRI once a year, are recommended after the discovery of a CCM, as additional asymptomatic lesions may appear with time. These MRI check-ups can be spaced to once every 5 years in the absence of intercurrent symptoms. Treatment of seizures and headaches is symptomatic. Lesions causing severe disabling seizures and/or focal neurologic deficits and/or cerebral hemorrhages call for surgical removal of lesions whenever possible. […] FCCM is an evolving condition with a strong correlation between the patient’s age and the number of CCM lesions. The hemorrhagic event rate is estimated at 2-5% per lesion per year. Functional outcome is mostly conditioned by the location of CCM lesions, with brainstem and basal ganglia lesions having a worse prognosis. Available data suggest that in most patients the long-term prognosis is quite favorable with a preserved autonomy in 80% of cases.

• #1 Cerebral Cavernous Malformation | University of Michigan Health

  https://www.uofmhealth.org/conditions-treatments/brain-neurological-conditions/cerebral-cavernous-malformation

  Cerebral cavernous malformations (CCMs), also known as cerebral cavernous angiomas, are collections of small blood vessels in the brain that become enlarged and irregular in shape. […] A diagnosis of the inherited form of CCM can be confirmed by genetic testing. […] CCMs are typically diagnosed via MRI when an individual becomes symptomatic. For most patients, MRIs are ordered when there are changes in symptoms. […] Medications are currently under development to strengthen blood vessels and stop the formation of additional CCMs. […] Patients with an increase in the size and number of lesions, or with an acute brain hemorrhage, may require surgery.

• #1

  https://neurolaunch.com/cavernoma-brain-mri/

  Treatment planning is another area where MRI shines. […] For patients with known cavernomas, periodic MRI scans become a part of life. […] The world of cavernoma imaging is not standing still. […] High-field strength MRI scanners, with their powerful 3 Tesla or even 7 Tesla magnets, are providing unprecedented levels of detail. […] Functional MRI (fMRI) is another game-changer. […] MRI-guided interventions are also on the rise. […] As we continue to peer deeper into the intricate workings of the brain, who knows what other secrets we might uncover, hidden in the folds and pathways of our own minds? […] The importance of expert interpretation cannot be overstated. […] For patients diagnosed with cavernomas, seeking care from specialists familiar with these lesions is crucial. […] As technology continues to advance, we can look forward to even more precise and informative imaging techniques.

• #1 Cavernous malformations – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/cavernous-malformations/diagnosis-treatment/drc-20360942

  Several medicines are being tested in clinical trials to see if specific medicines rather than surgery could reduce the chance of further bleeding. […] If a cerebral cavernous malformation is suspected, a referral to an experienced specialist can provide the best outcome. […] How many cavernous malformations do I have? […] Where is it, or where are they located? […] Should I have genetic tests? […] Should my children or anyone else in my family be tested? […] How often will I need follow-up tests? […] How often will I follow up with you? […] How long would you estimate I’d be in surgery? […] How long does surgery recovery usually take? […] How long should I plan to be in the hospital? […] How many CCMs have you seen, and how many have you treated? […] Does your institution have a cerebrovascular specialty practice?

• #1 Cavernous Malformation – 20 Questions Answered

  https://www.alliancetocure.org/home/for-patients/newly-diagnosed/20-questions-answered-cavernous-malformation-angioma-cavernoma/

  Most lesions never hemorrhage. However, once a cavernous malformation has had one hemorrhage, it is at a significantly greater risk of bleeding again. In the first five years after a hemorrhage, the risk of another hemorrhage in a cavernous malformation that is not in the brainstem is 17-20% (1 in 5 lesions will have a second hemorrhage). The risk of a second hemorrhage in brainstem cavernous malformations is greater at 30% (1 in 3 lesions will have a second hemorrhage). Most of these second hemorrhages will take place in the first two years after the original hemorrhage. […] If your cavernous malformation (cavernous angioma, cavernoma) is causing symptoms, you should have a very detailed discussion about surgical options with your neurosurgeon. The decision to have surgery always involves weighing risks and benefits. In general, experts recommend surgery if three criteria are met. First, the individual must have symptoms. Second, the cavernous malformation must have had at least two hemorrhages. Finally, removing the cavernous malformation will cause fewer deficits than another hemorrhage would.

• #1 Brain Cavernoma | Associate Professor of Neurological Surgery

  https://www.drleonlai.com/brain-cavernoma

  A cavernoma (or cavernous malformation) is a cluster of abnormal blood vessels (made up of veins), usually found in the brain and spinal cord. […] A diagnosis of the inherited form can be confirmed by genetic testing. […] Interestingly, the risk of bleeding from a cavernoma does not seem to relate to the size of the lesion, patients age or association with developmental venous malformation. […] In familial cases, bleeding rate may vary depending on the underlying genetic profile. […] Once a cavernoma has bled, the risk of rebleeding tend to increase. […] Most cavernomas do not require surgery. […] Symptomatic cavernomas causing seizures may be managed with medication, at least in the initial stages of the disease. […] Occasionally, cavernomas may require surgery due to recurrent bleeding or uncontrolled seizures despite appropriate medical treatment. […] When performed by a highly experienced neurosurgeon, surgery to remove the cavernoma is an excellent option. […] Some reports have shown a potential useful role of radiation therapy (stereotactic radiotherapy) in treatment cavernomas.

• #1 Cavernous malformation diagnosis [Neurosurgery Education Wiki]

  https://neurosurgery.education/wiki/doku.php?id=cavernous_malformation_diagnosis

  CMs were difficult to diagnose in the pre-MRI era. […] The introduction of MR imaging increased the number of diagnosed CMs as a CM that has hemorrhaged has a typical appearance on MR images (MRI). […] A CM diagnosed in a patient with an earlier normal MRI does not necessarily represent a denovo CM. […] Level I: brain MRI for the diagnosis and follow-up of known or suspected CMs. […] Level I: MRI should include gradient echo or susceptibility-weighted sequences. […] Not sensitive: CT misses many small lesions, some large ones, and even some that have bled. […] Not specific: CT findings may overlap with low-grade tumors, hemorrhages, granulomas. […] MRI appearance is nearly pathognomonic, and angiography is not necessary in classically appearing cases. […] First degree relatives of patients with more than one family member having a cavernous malformation should have MRI screening and appropriate genetic counseling.

• #2 Cavernous malformations – Diagnosis and treatment – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/cavernous-malformations/diagnosis-treatment/drc-20360942

  A Mayo Clinic neurologist talks with a person about a diagnosis. […] Depending on why the condition is suspected, your healthcare professional may order tests to confirm CCMs or to identify or rule out other related conditions. […] You may have imaging tests to look for changes in the blood vessels. […] An MRI is administered to a person. […] If you have a family history of the condition, genetic counseling and blood or saliva tests can help find gene changes related with CCMs. […] The tests can show if there’s bleeding or new CCMs. […] Your healthcare team reviews your symptoms and imaging tests to decide on a treatment plan. […] The care team may recommend closely watching the cavernous malformation is recommended. […] Or your care team may recommend removing or treating the cavernous malformation.

• #2 Cavernous Angioma (Malformation) Imaging and Diagnosis: Practice Essentials, Computed Tomography, Magnetic Resonance Imaging

  https://emedicine.medscape.com/article/337534-overview

  Cavernous angiomas (also variably termed cavernomas, cavernous malformations, and cavernous hemangiomas) are intracranial developmental malformations of the vascular bed that frequently enlarge over time. Approximately 80% of patients have the sporadic form of disease and 20% the familial form. The lesions may also develop years after radiotherapy. Patients may be asymptomatic, although they often present with headaches, seizures, or small parenchymal hemorrhages. The most common clinical manifestations are seizures (50%), intracranial hemorrhage (25%), and focal neurologic deficits (FND) without radiographic evidence of recent hemorrhage (25%). […] […] Most cavernous angiomas are diagnosed by MRI, which has been shown to have nearly 100% sensitivity. MRI is particularly valuable in identifying multiple lesions in familial disease. Three-dimensional postcontrast T1-weighted MRI is essential to identify associated developmental venous anomalies, which is important for both diagnosis and surgical planning. Contrast-enhanced MRI should be performed to diagnose hemorrhagic cavernous malformations and to differentiate them from spontaneous solitary hematomas or hemorrhagic tumors. […]

• #2 Imaging – Alliance to Cure Cavernous Malformation

  https://www.alliancetocure.org/cavernous-angioma-in-depth/diagnosis-imaging/

  While some people with cavernous malformations (also known as cavernoma, cavernous angioma) receive their diagnosis through genetic testing or surgery, the vast majority are diagnosed via imaging, typically magnetic resonance imaging (MRI). Imaging technology has advanced over the years and research into new techniques is ongoing. […] An MRI is the standard of care for cavernous malformation, especially when performed on an MRI machine with a magnet strength of 3 Tesla (3T) or 7 Tesla (7T, currently used in research settings) and when the imaging includes susceptibility-weighted sequences (SWI). Specific recommendations for physicians who order or perform MRI are included in the Alliance to Cure Cavernous Malformation Clinical Care Consensus Guidelines. […] A distinctive feature of a cavernous malformation when it is visualized on MRI is the hemosiderin ring around the lesion. Hemosiderin is iron, a byproduct of the breakdown of blood.

• #2

  https://journals.lww.com/neur/fulltext/2024/09000/is_there_any__unbled__cavernoma_.44.aspx

  The most significant predictor for a rebleed in a cavernoma is evidence of a prior bleed, implying that a bled cavernoma needs to be treated on priority compared to an unbled cavernoma, which may be observed. […] A cavernoma may increase in size because of small intralesional hemorrhages or from spontaneous thrombosis of the blood-filled caverns. […] It brings us to a contentious question, what is the evidence of an unbled cavernoma? This entity has not been described in any surgical series. During surgery a hemosiderin ring has always been found implying a previous bleed. Based on the current established criteria, a cavernoma is visible on radiology only when it has bled. Else it cannot be diagnosed on the scans and this also includes the so-called incidentalomas. If a cavernoma is seen on CT/MRI, it means it has already bled in the past.

• #2 Imaging – Alliance to Cure Cavernous Malformation

  https://www.alliancetocure.org/cavernous-angioma-in-depth/diagnosis-imaging/

  Research is ongoing to validate and standardized two advanced techniques in MRI imaging: quantitative susceptibility mapping (QSM) and dynamic contrast-enhanced quantitative permeability imaging (DCEQP). Both of these techniques are being used in clinical drug trials to measure whether medicine is making a difference in the activity of a cavernous malformation. […] Functional MRI (fMRI) provides information on the precise location of certain functions, for example, speech, in the brain. It may be used before surgery to allow the surgeon to plan a route to the cavernous malformation lesion that avoids a specific area.

• #2 Cerebral cavernous malformation diagnosis [Neurosurgery Education Wiki]

  https://neurosurgery.education/wiki/doku.php?id=cerebral_cavernous_malformation_diagnosis

  Cerebral Cavernous malformation (CCM) diagnosis occurs more frequently than some years ago, due to the increased diffusion of magnetic resonance imaging. […] MRI is the modality of choice, demonstrating a characteristic popcorn or berry appearance with a rim of signal loss due to hemosiderin, which demonstrates prominent blooming on susceptibility weighted sequences. […] The SWI sequence, being more sensitive to substances which distort the local magnetic field than the GRE T2*W sequence, showed a higher sensitivity in identifying cerebral cavernous malformations. Thus, routine clinical neuroimaging protocol should contain SWI sequences to evaluate patients with (or suspected) cerebral cavernous malformations. […] Quantitative Susceptibility Mapping (QSM) MRI allows accurate assessment of iron content in cerebral cavernous malformations (CCM), and a threshold increase by 6% in QSM has been shown to reflect new symptomatic hemorrhage (SH) in previously stable lesions. […] The change in mean lesional QSM of index hemorrhagic lesions was +7.93% per patient-year in the whole cohort.

• #2 Cavernous Malformations | Boston Children’s Hospital

  https://www.childrenshospital.org/conditions/cavernous-malformations

  Cavernous malformations are usually diagnosed and evaluated by using magnetic resonance imaging (MRI) and computed tomography (CT). […] Unlike most other cerebrovascular conditions, cavernous malformations are difficult or impossible to see on angiograms, because the blood flow within the malformations is very slow and because the vessels feeding them are so tiny.

• #2 Cavernous malformations – Symptoms and causes – Mayo Clinic

  https://www.mayoclinic.org/diseases-conditions/cavernous-malformations/symptoms-causes/syc-20360941

  Cerebral cavernous malformations (CCMs) are groups of tightly packed, irregular small blood vessels with thin walls. […] A diagnosis can be confirmed by a genetic test that requires a blood or saliva sample. […] Genetic testing is often recommended for people who have: MRI evidence of multiple CCMs without a DVA. […] Seek medical help right away if you experience any symptoms of a seizure. Also get immediate medical help if you have symptoms that suggest a cerebral cavernous malformation or brain bleeding. […] Most cerebral cavernous malformations (CCMs) are known as the „sporadic form.” […] However, about 20% of people with a CCM have a genetic form. […] Radiation to the brain or spinal cord also may result in CCMs within 2 to 20 years afterward. […] The most serious complications of cerebral cavernous malformations (CCMs) stem from repeated bleeding, known as hemorrhages. […] Bleeding is more likely to return in people with prior hemorrhages.

• #2

  https://link.springer.com/article/10.1007/s00701-018-3735-1

  Hubert Luschka was the first to describe a cerebral Cavernse Blutgeschwulst (cavernous malformation) in 1854. […] Today, the terms cavernoma, cavernous hemangioma, cavernous angioma, and cavernous malformation are used interchangeably and appear equally frequent in the literature. The diagnosis is always based on MRI, sometimes with histopathology as verification. […] The introduction of MR imaging increased the number of diagnosed CMs as a CM that has hemorrhaged has a typical appearance on MR images (MRI). An unruptured CM cannot, however, be seen. […] The above as well as the articles in the present issue of Acta Neurochirurgica highlight the need for further analysis and investigation of this phenomenon. […] We believe that this is the case and we therefore suggest the term pseudocavernoma to describe radiation-induced changes mimicking a CM, and the reasons are given below.

• #2 SciELO Brazil – Neurocysticercosis, familial cerebral cavernomas and intracranial calcifications: differential diagnosis for adequate management Neurocysticercosis, familial cerebral cavernomas and intracranial calcifications: differential diagnosis for

  https://www.scielo.br/j/anp/a/pKsTMJ4757wpkzmcYwssGQR/

  Epilepsy is the more common manifestation of the cerebral cavernomas, with most studies showing seizures as leading symptom in 40% to 70% of the cases. […] The misdiagnosis between the NCC and FCCM has several important consequences deserving awareness of the medical and, specially, neurologic community. […] In conclusion, with the widespread access to the MRI technology it might be worthwhile to consider reviewing the prevalent paradigm for NCC diagnosis, when calcified cysts are detected in cranial CT in patients suffering from seizures in endemic areas. […] In the geographical areas where NCC still prevails as an important endemic health problem the differential diagnosis with familial cavernous malformations should be taken into consideration whenever facing patients with seizures and multiple intracranial calcifications on CT scan, for the adequate management of the diseases.

• #2 Cavernoma Program | Pacific Stroke & Neurovascular Center

  https://www.pacificneuroscienceinstitute.org/stroke-neurovascular/conditions-and-treatments/brain-vascular-malformation/cavernoma/cavernoma-program/

  The Cavernoma Program specializes in advanced diagnostics to optimize treatment decisions, including state-of-the-art brain imaging and genetic profiling of vascular malformations to identify targets for therapeutic intervention. […] We use state-of-the-art brain imaging techniques (called diffusion tensor tractography, gradient echo and susceptibility weighted sequences) that allow for noninvasive and computational treatment planning. […] Most cavernomas only need to be observed with routine brain imaging, repeated over time to observe for changes in appearance, recent bleeding (hemorrhage) or appearance of new lesions. […] The Cavernoma Program is also a leader in advanced research initiatives to develop targeted molecular therapies with the goal of preventing new cavernoma formation and protecting against symptomatic bleeding.

• #2 Cerebral Cavernous Malformation – UChicago Medicine

  https://www.uchicagomedicine.org/conditions-services/neurology-neurosurgery/stroke-neurovascular-care/ccm

  They are developing ways to diagnose and measure CCM disease with imaging tools, including permeability or subtle leakage in lesions and the brain and the measurement of iron levels in lesions. […] Many of our patients participate in CCM research by allowing our team to analyze the data collected during their enhanced MRI scans. […] Each project is approved by the Institutional Review Board at University of Chicago Medicine.

• #3 Cerebral Cavernous Malformation Diagnosis – UChicago Medicine

  https://www.uchicagomedicine.org/conditions-services/neurology-neurosurgery/stroke-neurovascular-care/ccm/diagnosis-management

  Cavernous angiomas usually are not detected until a person becomes symptomatic. At the University of Chicago Medicine, our experts have unmatched experience in the definitive diagnosis of CCM. Our team of specialists will conduct a comprehensive diagnostic evaluation, including: […] MRI is the most reliable imaging technique for CCM diagnosis. The condition may go undetected with other imaging methods. Before MRI was widely used, people with CCM were commonly misdiagnosed with multiple sclerosis (MS) or a seizure disorder, partially because the lesion was not detected on imaging scans.

• #3 Cerebral cavernous malformation diagnosis [Neurosurgery Education Wiki]

  https://neurosurgery.education/wiki/doku.php?id=cerebral_cavernous_malformation_diagnosis

  Cerebral Cavernous malformation (CCM) diagnosis occurs more frequently than some years ago, due to the increased diffusion of magnetic resonance imaging. […] MRI is the modality of choice, demonstrating a characteristic popcorn or berry appearance with a rim of signal loss due to hemosiderin, which demonstrates prominent blooming on susceptibility weighted sequences. […] The SWI sequence, being more sensitive to substances which distort the local magnetic field than the GRE T2*W sequence, showed a higher sensitivity in identifying cerebral cavernous malformations. Thus, routine clinical neuroimaging protocol should contain SWI sequences to evaluate patients with (or suspected) cerebral cavernous malformations. […] Quantitative Susceptibility Mapping (QSM) MRI allows accurate assessment of iron content in cerebral cavernous malformations (CCM), and a threshold increase by 6% in QSM has been shown to reflect new symptomatic hemorrhage (SH) in previously stable lesions. […] The change in mean lesional QSM of index hemorrhagic lesions was +7.93% per patient-year in the whole cohort.

• #3 Imaging – Alliance to Cure Cavernous Malformation

  https://www.alliancetocure.org/cavernous-angioma-in-depth/diagnosis-imaging/

  Research is ongoing to validate and standardized two advanced techniques in MRI imaging: quantitative susceptibility mapping (QSM) and dynamic contrast-enhanced quantitative permeability imaging (DCEQP). Both of these techniques are being used in clinical drug trials to measure whether medicine is making a difference in the activity of a cavernous malformation. […] Functional MRI (fMRI) provides information on the precise location of certain functions, for example, speech, in the brain. It may be used before surgery to allow the surgeon to plan a route to the cavernous malformation lesion that avoids a specific area.

Zobacz więcej